跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAELYX CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/10ML - PPB Drug Approval Details
Approvals
/
PPB
/
CAELYX CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/10ML
Approved
STANDARD
CAELYX CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/10ML
BAXTER HEALTHCARE LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
3461f1c70b9d07df
Company
BAXTER HEALTHCARE LIMITED
Type
Standard
Approval Details
Approval Id
3461f1c70b9d07df
Product Name
CAELYX CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/10ML
Drug Hk Name
CAELYX CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/10ML
Registration Code
HK-66647
Company Name
BAXTER HEALTHCARE LIMITED
Company Detail Path
/organization/baxter-healthcare-limited
Registration Category
Antibiotic
Sale Requirement
Prescription only Medicines
Registration Date
2020-04-21
Company Address
ROOM 1802, 8, QUEEN'S ROAD EAST, WAN CHAI, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
3461f1c70b9d07df
Type
Standard
Back to PPB Approvals
